Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Merck”
- A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Arthritis, Rheumatoid
United States, Canada, Chile, China, Colombia +6 more
Sponsor: Merck Sharp & Dohme LLC
Warts, Genital · Neoplasms, Anal
Japan
Sponsor: University of Wisconsin, Madison
Cytomegalovirus Infections · Kidney Transplant Infection · Pancreas Transplant
United States
- A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal CancerActive Not Recruiting
Sponsor: Pfizer
Neoplasms
United States, Argentina, Australia, Belgium, Brazil +24 more
- Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell LymphomaRecruiting
Sponsor: Yale University
T-Cell Lymphoma
United States
- A Study of MK-7240 in Healthy Participants (MK-7240-009)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Healthy
Australia
Sponsor: Virginia Commonwealth University
Prostate Cancer · Neuroendocrine Prostate Cancer (NEPC)
United States
- Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural MesotheliomaActive Not Recruiting
Sponsor: Hyogo Medical University
Malignant Pleural Mesothelioma
Japan
- A Study of Sotatercept in Japanese Pulmonary Arterial Hypertension (PAH) Participants (MK-7962-020)Completed
Sponsor: Merck Sharp & Dohme LLC
Pulmonary Arterial Hypertension
Japan
- Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)Not Yet Recruiting
Sponsor: Dana-Farber Cancer Institute
HPV-positive Oropharyngeal Squamous Cell Carcinoma · Oropharyngeal Squamous Cell Carcinoma
United States
Sponsor: Merck Sharp & Dohme LLC
Healthy
United States
- Study of the Effects of Pembrolizumab in Patients With Advanced Solid TumorsActive Not Recruiting
Sponsor: University Health Network, Toronto
Squamous Cell Cancer of Head and Neck · Triple Negative Breast Cancer · Epithelial Ovarian Cancer · Malignant Melanoma
Canada
Sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
Pulmonary Arterial Hypertension
United States, Argentina, Australia, Austria, Belgium +22 more
Sponsor: Merck Sharp & Dohme LLC
Advanced Non-Small Cell Lung Cancer
United States, Australia, Canada, Hong Kong, Ireland +11 more
Sponsor: University of Colorado, Denver
Gastric Cancer · GastroEsophageal Cancer
United States
Sponsor: Merck Sharp & Dohme LLC
Advanced or Metastatic Solid Tumors
Chile, Hungary, Japan, South Africa, South Korea +1 more
- Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain MetastasisActive Not Recruiting
Sponsor: UNICANCER
Malignant Melanoma · BRAF V600 Mutation · Brain Metastases
France
Sponsor: Merck Sharp & Dohme LLC
Advanced Solid Tumors
United States, Australia, Chile, China, Israel +1 more
- REVIVE (Response to the Ebola Virus Vaccine)Active Not Recruiting
Sponsor: Tulane University
Ebola Virus Disease
Sierra Leone
- Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell CarcinomaTerminated
Sponsor: Yale University
Melanoma · Renal Cell Carcinoma · Brain Metastases · PD1/PD-L1 Experienced
United States
Sponsor: Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma
Spain
Sponsor: Filipa Lynce, MD
Breast Cancer · Breast Cancer Female · Triple Negative Breast Cancer · Hormone Receptor Negative Malignant Tumor Breast Triple
United States
Sponsor: Gates Medical Research Institute
Tuberculosis
United States
Sponsor: Memorial Sloan Kettering Cancer Center
Urothelial Carcinoma
United States
Sponsor: Herbert Lyerly
Breast Cancer · HER2+ Breast Cancer
United States